Clinical Trials Sponsored by Centrexion Therapeutics
Total 6258 results
-
Blade TherapeuticsWithdrawnIdiopathic Pulmonary FibrosisUnited Kingdom
-
Cristal TherapeuticsCompletedCancer | Ovarian CancerNetherlands, Belgium, United Kingdom
-
Amicus TherapeuticsCompletedOpen-Label Extension Study of the Long-Term Effects of Migalastat HCL in Patients With Fabry DiseaseFabry DiseaseUnited States, Austria, United Kingdom, Argentina, Australia, Belgium, Brazil, Canada, Denmark, Egypt, France, Italy, Japan, Spain, Turkey
-
PTC TherapeuticsCompletedDuchenne Muscular Dystrophy | Becker Muscular Dystrophy | DystrophinopathyUnited Kingdom, Canada, Germany, Spain, Sweden, Italy, Australia, Belgium, France, Israel
-
Arthrosi TherapeuticsCompletedHealthy VolunteersAustralia
-
Symbiomix TherapeuticsCompleted
-
United TherapeuticsTerminatedPulmonary Hypertension | Heart Failure With Preserved Ejection FractionUnited States
-
AKARI TherapeuticsCompletedParoxysmal Nocturnal Hemoglobinuria (PNH)Kazakhstan, Lithuania, Sri Lanka
-
Effector TherapeuticsTerminated
-
Blade TherapeuticsWithdrawn
-
Trevi TherapeuticsCompletedPrurigo Nodularis | Prurigo | Nodularis PrurigoGermany
-
Shield TherapeuticsCompletedInflammatory Bowel Diseases | Anemia, Iron DeficiencyUnited Kingdom
-
United TherapeuticsTerminatedPulmonary Hypertension Associated With HFpEFUnited States
-
Promethera TherapeuticsCompletedNASH - Nonalcoholic SteatohepatitisSpain, Belgium, Bulgaria, France
-
Spero TherapeuticsCompleted
-
Cyclerion TherapeuticsCompletedHypertension | Diabetes Mellitus, Type 2United States
-
PTC TherapeuticsCompletedFriedreich's AtaxiaUnited States
-
Aquestive TherapeuticsCompleted
-
Sage TherapeuticsWithdrawn
-
Aquestive TherapeuticsCompleted
-
Therapeutics, Inc.CompletedScalp PsoriasisUnited States
-
PTC TherapeuticsCompleted
-
Agile TherapeuticsCompleted
-
Balance TherapeuticsUnknownIdiopathic HypersomniaUnited States
-
Corcept TherapeuticsCompletedAntipsychotic-induced Weight GainUnited Kingdom
-
PTC TherapeuticsTerminatedCystic FibrosisUnited States, Spain, France, Belgium, United Kingdom, Australia, Brazil, Bulgaria, Canada, Germany, Israel, Italy, Netherlands, Poland, Argentina, Greece
-
Cyclerion TherapeuticsCompletedHypertension | Diabetes Mellitus, Type 2United States
-
PTC TherapeuticsTerminatedCystic FibrosisUnited States, France, Spain, Belgium, Israel, Italy, Sweden
-
Prexton TherapeuticsCompletedParkinson DiseaseFrance, Italy, Spain, Germany, United Kingdom, Austria
-
MC2 TherapeuticsCompletedPhotoallergyUnited States
-
PTC TherapeuticsCompleted
-
Pendulum TherapeuticsCompletedType 2 Diabetes MellitusUnited States
-
Aerpio TherapeuticsCompletedPrimary Open Angle Glaucoma | Ocular HypertensionUnited States
-
Stayble TherapeuticsCompleted
-
Celldex TherapeuticsCompletedGlioblastoma | Gliosarcoma | Recurrent Glioblastoma | Small Cell Glioblastoma | Giant Cell Glioblastoma | Glioblastoma With Oligodendroglial Component | Relapsed GlioblastomaUnited States
-
Halozyme TherapeuticsTerminatedCholangiocarcinoma Non-resectable | Cholangiocarcinoma, Extrahepatic | Cholangiocarcinoma, Intrahepatic | Gallbladder AdenocarcinomaUnited States, Korea, Republic of, Thailand
-
Entasis TherapeuticsCompletedAcute Pyelonephritis | Complicated Urinary Tract InfectionBulgaria
-
MC2 TherapeuticsCompleted
-
Atacama TherapeuticsCompletedPalmar HyperhidrosisUnited States
-
MC2 TherapeuticsCompleted
-
PTC TherapeuticsWithdrawn
-
Heron TherapeuticsCompleted
-
Cytori TherapeuticsSuspendedThermal BurnUnited States
-
Celldex TherapeuticsTerminated
-
Entasis TherapeuticsCompletedAcinetobacter Baumannii-calcoaceticus Complex InfectionsUnited States
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Poland, Spain
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States, Canada
-
Corcept TherapeuticsTerminatedCushing Syndrome | HypercortisolismUnited States
-
Effector TherapeuticsTerminatedHepatocellular Carcinoma | Triple Negative Breast CancerUnited States